Recruiting
Phase 2

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Sponsor:

National Cancer Institute (NCI)

Code:

NCT03206060

Conditions

Pheochromocytoma

Paraganglioma

Neuroendocrine Tumors

Neuroendocrine Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lu-177-DOTATATE

Ga-68-DOTATATE

F-18-FDG

Amino Acid solution

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information